You just read:

INCIVO® (Telaprevir) Demonstrates Efficacy and Increased Cure Rates Among Cirrhotic Patients With Genotype-1 Chronic HCV Compared to Standard of Care

News provided by

Janssen Pharmaceutica NV

05 Nov, 2011, 13:29 GMT